329 results on '"Nakamura, Nobuhiko"'
Search Results
52. Decreased Expression of Glucose and Peptide Transporters in Rat Remnant Kidney
53. Investigation of Velocity Profiles in Oscillating Flows Inside a Pulse Tube Refrigerator
54. Radial Temperature and Velocity Profiles of Oscillating Flows in a Pulse Tube Refrigerator
55. Estimation of Plant Growth in Rice Field Based on Remote Sensing
56. A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma
57. The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma
58. Recovery of Pure Red Cell Aplasia Following Hematopoietic Stem Cell Transplantation Associated with Interleukin (IL)-6 Elevation Caused by Odontogenic Infection
59. Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia
60. An effect of comprehensive geriatric assessment in elderly patients with non-Hodgkin lymphoma treated with chemotherapy
61. R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial
62. Gender differences in expression of organic cation transporter OCT2 in rat kidney
63. Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice
64. Endoscopic Examination for Patients with Diarrhea after Allogeneic Stem Cell Transplantation
65. Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin’s Lymphoma
66. Time-Series Modeling and Simulation for Comparative Cost-Effective Analysis in Cancer Chemotherapy: An Application to Platinum-Based Regimens for Advanced Non-small Cell Lung Cancer
67. Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era
68. The Roles of Aryl Hydrocarbon Receptor in T Cells at IDO-Positive Tumor Microenvironment
69. Retreatment with bendamustine in patients with relapsed/refractory indolent B-cell lymphoma and mantle cell lymphoma
70. Serum concentrations ofl-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified
71. A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemother
72. O3-3-2 - An effect of comprehensive geriatric assessment in elderly patients with non-Hodgkin lymphoma treated with chemotherapy
73. Prognostic value of the combination of seruml-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia
74. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis
75. Garenoxacin Prophylaxis for Febrile Neutropenia after Chemotherapy in Hematological Malignancies
76. Automatic Equipment of Visual Acuity Test by Use of a Microcomputer
77. Rituximab Maintenance for Aggressive B Cell Lymphoma Improves Outcomes Only in Rituximab Naive Patients, Results from a Meta-Analysis
78. The Incidence and the Risk Factors of Bowel Perforation Due to Chemotherapy in Gastrointestinal Diffuse Large B Cell Lymphoma
79. Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia
80. The Value of Combination of Serum L-Kynurenine Level and Expression of Indoleamine 2,3-Dioxygenase mRNA As a Prognostic Factor in Acute Myeloid Leukemia
81. Bendamustine therapy for relapsed or refractory low grade B cell lymphoma and mantle cell lymphoma
82. Efficacy and safety of denosumab for multiple myeloma
83. A retrospective study of D-index in acute myeloid leukemia patients undergoing induction chemotherapy
84. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin
85. Abstract 4201: Development of a syngeneic metastatic mouse model of malignant lymphoma
86. High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia
87. Prospective PhaseⅡ Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation
88. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
89. A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemotherapy.
90. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
91. Peripheral T-Cell Lymphoma, Not Otherwise Specified and Concurrent Seminoma in Testis
92. A Comparison of THP- Cop and CHOP for Peripheral T-Cell Lymphoma, Not Otherwise Specified
93. High Response Rate and Acceptable Toxicity of R-P-Imvp-16/CBDCA for Relapsed or Refractory Aggressive B-Cell Lymphoma
94. Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics
95. Clinical Significance of Serum Concentration of L-Kynurenine for Peripheral T-Cell Lymphoma, not Otherwise Specified
96. Efficacy and Safety of Rituximab Combined with P-Imvp-16/Cbdca for Refractory or Relapsed Aggressive B-Cell Lymphoma
97. Retreatment with Bendamustine in Patients with Relapsed/Refractory Indolent B-Cell Lymphoma and Mantle Cell Lymphoma
98. O2-12-3 - Retreatment with bendamustine in patients with relapsed/refractory indolent B-cell lymphoma and mantle cell lymphoma
99. Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma
100. Serum Soluble Tumor Necrosis Factor Receptor 1 Level is Associated with the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with the CHOP or R-CHOP Regimen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.